The role of 5-HT7 receptor antagonism in the amelioration of MK-801-induced learning and memory deficits by the novel atypical antipsychotic drug lurasidone

Behavioural Brain Research

Volumn 244, Issue , 2013, Pages 66-69

  Horisawa, Tomoko ^a   Nishikawa, Hiroyuki ^a   Toma, Satoko ^a   Ikeda, Atsushi ^a   Horiguchi, Masakuni ^a   Ono, Michiko ^a   Ishiyama, Takeo ^a   Taiji, Mutsuo ^a  

^a DAINIPPON SUMITOMO PHARMA CO LTD   (Japan)

Author keywords

5 HT7; Antipsychotic; Cognition; Lurasidone; Passive avoidance

Indexed keywords

5 (1,3,5 TRIMETHYLPYRAZOL 4 YL) 2 (DIMETHYLAMINO) TETRALIN; DIZOCILPINE; KETANSERIN; LURASIDONE; RACLOPRIDE; SB 656104A; SEROTONIN AGONIST; SEROTONIN ANTAGONIST; UNCLASSIFIED DRUG; AS 19 COMPOUND; DIZOCILPINE MALEATE; DOPAMINE RECEPTOR BLOCKING AGENT; ISOINDOLE DERIVATIVE; NEUROLEPTIC AGENT; PHENOL DERIVATIVE; PYRAZOLE DERIVATIVE; PYRROLIDINE DERIVATIVE; SB 656104 A; SB-656104-A; SEROTONIN 7 RECEPTOR; SEROTONIN RECEPTOR; TETRALIN DERIVATIVE; THIAZOLE DERIVATIVE;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; COGNITION; COGNITIVE DEFECT; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; DRUG EFFICACY; DRUG MECHANISM; LEARNING DISORDER; MALE; NONHUMAN; PASSIVE AVOIDANCE; PRIORITY JOURNAL; RAT; RECEPTOR BLOCKING; ANIMAL; AVOIDANCE BEHAVIOR; DRUG ANTAGONISM; DRUG EFFECT; MEMORY;

ANIMALS; ANTIPSYCHOTIC AGENTS; AVOIDANCE LEARNING; DIZOCILPINE MALEATE; DOPAMINE ANTAGONISTS; ISOINDOLES; KETANSERIN; MALE; MEMORY; PHENOLS; PYRAZOLES; PYRROLIDINES; RACLOPRIDE; RATS; RECEPTORS, SEROTONIN; SEROTONIN ANTAGONISTS; SEROTONIN RECEPTOR AGONISTS; TETRAHYDRONAPHTHALENES; THIAZOLES;

EID: 84874353764     PISSN: 01664328     EISSN: 18727549     Source Type: Journal    
DOI: 10.1016/j.bbr.2013.01.026     Document Type: Article

References (24)

1. Keefe S.E. Cognitive deficits in patients with schizophrenia: effects and treatment. Journal of Clinical Psychiatry 2007, 68(Suppl. 14):8-13.
2. Green M.F. Cognitive impairment and functional outcome in schizophrenia and bipolar disorder. Journal of Clinical Psychiatry 2006, 67(Suppl. 9):3-8.
3. Buchanan R.W., Keefe R.S., Umbricht D., Green M.F., Laughren T., Marder S.R. The FDA-NIMH-MATRICS guidelines for clinical trial design of cognitive enhancing drugs: what do we know 5 years later?. Schizophrenia Bulletin 2010, 37:1209-1217.
4. Coyle J.T. Glutamate and schizophrenia: beyond the dopamine hypothesis. Cellular and Molecular Neurobiology 2006, 26:365-384.
5. Krystal J.H., D'Souza D.C., Mathalon D., Perry E., Belger A., Hoffman R. NMDA receptor antagonist effects, cortical glutamatergic function, and schizophrenia: toward a paradigm shift in medication development. Psychopharmacology 2003, 169:215-233.
6. Jentsch J.D., Roth R.H. The neuropsychopharmacology of phencyclidine: From NMDA receptor hypofunction to the dopamine hypothesis of schizophrenia. Neuropsychopharmacology 1999, 20:201-225.
7. Rujescu D., Bender A., Keck M., Hartmann A.M., Ohl F., Raeder H., et al. A pharmacological model for psychosis based on N-methyl-d-aspartate receptor hypofunction: molecular, cellular, functional and behavioral abnormalities. Biological Psychiatry 2006, 59:721-729.
8. 1A receptor activity. Journal of Pharmacology and Experimental Therapeutics 2010, 334:171-181.
9. Harvey P.D., Ogasa M., Cucchiaro J., Loebel A., Keefe R.S.E. Performance and interview-based assessments of cognitive change in a randomized, double-blind comparison of lurasidone vs. ziprasidone. Schizophrenia Research 2011, 127:188-194.
10. Enomoto T., Ishibashi T., Tokuda K., Ishiyama T., Toma S., Ito A. Lurasidone reverses MK-801-induced impairment of learning and memory in the Morris water maze and radial-arm maze tests in rats. Behavioural Brain Research 2008, 186:197-207.
11. Horiguchi M., Huang M., Meltzer H.Y. The role of 5-hydroxytryptamine 7 receptors in the phencyclidine-induced novel object recognition deficit in rats. Journal of Pharmacology and Experimental Therapeutics 2011, 338:605-614.
12. Ishiyama T., Tokuda K., Ishibashi T., Ito A., Toma S., Ohno Y Lurasidone (SM-13496), a novel atypical antipsychotic drug, reverses MK-801-induced impairment of learning and memory in the rat passive-avoidance test. European Journal of Pharmacology 2007, 572:160-170.
13. 1A receptors on MK-801-induced impairment of learning and memory in the passive avoidance and Morris water maze tests in rats: Mechanistic implications for the beneficial effects of the novel atypical antipsychotic lurasidone. Behavioural Brain Research 2011, 220:83-90.
14. 2 receptor antagonists on a cranial nerve reflex in the rabbit: evidence for inverse agonism. Psychopharmacology 1999, 141:162-168.
15. Millan M.J., Newman-Tancredi A., Brocco M., Gobert A., Lejeune F., Audinot V., et al. S18126 ({2-[4-(2,3-dihydrobenzo[1,4]dioxin-6-yl)piperazin-1-ylmethyl]indan-2-yl}), a potent, selective and competitive antagonist at dopamine D4 receptors: an in vitro and in vivo comparison with L745,870 (3-(4-[4-chlorophenyl]piperazin-1-yl)methyl-1H-pyrrolo[2,3b]pyridine) and raclopride. Journal of Pharmacology and Experimental Therapeutics 1998, 287:167-186.
16. Meltzer H.Y., Horiguchi M., Massey B.W. The role of serotonin in the NMDA receptor antagonist models of psychosis and cognitive impairment. Psychopharmacology 2011, 213:289-305.
17. 7 antagonist SB-269970 in the modulation of working and reference memory in the rat. Behavioural Brain Research 2008, 195:164-170.
18. Waters K.A., Stean T.O., Hammond B., Virley D.J., Upton N., Kew J.N.C., et al. Effects of the selective 5-HT7 receptor antagonist SB-269970 in animal models of psychosis and cognition. Behavioural Brain Research 2012, 228:211-218.
19. 7 receptors show specific impairments in contextual learning. European Journal of Neuroscience 2004, 19:1913-1922.
20. 7 receptor is involved in allocentric spatial memory information processing. Behavioural Brain Research 2009, 202:26-31.
21. 7 receptor agonist AS19 in an autoshaping learning task. Behavioural Brain Research 2005, 163:136-140.
22. Yuen E.U., Li X., Wei J., Horiguchi M., Meltzer H.Y., Yan Z. The novel antipsychotic drug lurasidone enhances NMDA receptor-mediated synaptic responses. Molecular Pharmacology 2012, 81:113-119.
23. 7 receptor reverses working memory deficits in rats by normalizing cortical glutamate neurotransmission. PLoS ONE 2011, 6:1-7.
24. 1A Receptors in phencyclidine (PCP)-induced novel object recognition (NOR) deficit in rats. Psychopharmacology 2012, 221:205-215.